• OPEN AN ACCOUNT
Indian Indices
Sensex
73,852.90 -876.37
( -1.17%)
Global Indices
Nasdaq
51,986.54 -36.87
(-0.07%)
Dow Jones
7,712.39 31.95
(0.42%)
Hang Seng
63,869.15 -1,047.55
(-1.61%)
Nikkei 225
10,765.28 -116.62
(-1.07%)
Forex
USD-INR
94.77 -0.08
(-0.08%)
EUR-INR
106.47 0.12
(0.11%)
GBP-INR
126.26 0.54
(0.43%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532649
INE023H01027
29.975558
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECLIFE
0
215.05
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

simplex papers ltd
Coforge introduces intent engineering framework for optimizing AI agents
Oct 05,2026

Coforge introduced its intent engineering framework, a practical design methodology that helps enterprises build agentic AI systems aligned to business outcomes, governance requirements, and operational realities.

As enterprises move autonomous AI agents into customer-facing and operational workflows, the consequences of misaligned decisions become increasingly significant. While prompt engineering influences responses and context engineering improves decision quality, neither guarantees that agents optimize for the outcomes businesses actually value. Coforge believes that intent engineering bridges that gap and is rapidly becoming a critical requirement for enterprise-scale AI adoption.